Reid G. Adler - May 2, 2022 Form 3 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
May 2, 2022
Transactions value $
$0
Form type
3
Date filed
5/3/2022, 05:07 PM
Next filing
Aug 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VTGN Common Stock 34.6K May 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 2.5K $8.00 Direct F1
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 50K $1.56 Direct F2
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 25K $1.16 Direct F3
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 20K $1.00 Direct F4
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 25K $1.41 Direct F5
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 25K $0.40 Direct F6
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 50K $2.74 Direct F7
holding VTGN Stock Option (Right to Buy) May 2, 2022 Common Stock 50K $1.37 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options are fully vested as of the date of this report.
F2 Stock options are fully vested as of the date of this report.
F3 Stock options are fully vested as of the date of this report.
F4 Stock options are fully vested as of the date of this report.
F5 Stock options are fully vested as of the date of this report.
F6 Stock options are fully vested as of the date of this report.
F7 25% of the stock options vested on July 16, 2021 (the "Vesting Start Date") and 1/24th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.
F8 25% of the stock options vested on March 1, 2022 (the "Vesting Start Date") and 1/24th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.